Hearing loss in adults surviving pneumococcal meningitis is associated with otitis and pneumococcal serotype

Clinical Microbiology and Infection

Volumn 18, Issue 9, 2012, Pages 849-855

  Heckenberg, S G B ^a   Brouwer, M C ^a   Van der Ende, A ^b,c   Hensen, E F ^d   Van de Beek, D ^a  

^a Departments of Neurology   (Netherlands)

^b Centre of Infection and Immunity Amsterdam (CINIMA)   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CNS infection; Meningitis; Pneumococcal meningitis; Pneumococcal serotype; S. pneumoniae

Indexed keywords

ADULT; AGED; ARTICLE; AUDIOGRAPHY; CEREBROSPINAL FLUID; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; HEARING LOSS; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFLAMMATION; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OTITIS; PERILYMPHATIC INFLAMMATION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE TONE AVERAGE; RISK FACTOR; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVOR;

EID: 84865282857     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03668.x     Document Type: Article

References (29)

1. van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med 2006; 354: 46-55.
2. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23: 467-492.
3. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: 1849-1859.
4. Worsoe L, Caye-Thomasen P, Brandt CT, Thomsen J, Ostergaard C. Factors associated with the occurrence of hearing loss after pneumococcal meningitis. Clin Infect Dis 2010; 51: 917-924.
5. Klein M, Koedel U, Kastenbauer S, Pfister HW. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment. Infection 2008; 36: 2-14.
6. Dodge PR, Davis H, Feigin RD et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984; 311: 869-874.
7. Ostergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis 2005; 5: 93.
8. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006; 5: 123-129.
9. Weisfelt M, de Gans J, van der Poll T, van de Beek D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 2006; 5: 332-342.
10. Peltola H, Roine I, Fernández J et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics 2010; 125: e1-e8.
11. Adachi N, Ito K, Sakata H. Risk factors for hearing loss after pediatric meningitis in Japan. Ann Otol Rhinol Laryngol 2010; 119: 294-296.
12. Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect 2010; 61: 114-124.
13. Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010; 75: 1533-1539.
14. Jennett B, Teasdale G. Management of Head Injuries, 2nd edn. Philadelphia: FA Davis, 1981.
15. ISO institute. Acoustics-Statistical distribution of hearing thresholds as a function of age, 2nd edn. Geneva, Switzerland: ISO Institute, 2000. Stage: 90.92, ICS: 13.140.
16. Dobie RA, Black FO, Pezsnecker SC, Stallings VL. Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy. Arch Otolaryngol Head Neck Surg 2006; 132: 253-257.
17. De Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
18. van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 2004; 4: 139-143.
19. Joglekar S, Morita N, Cureoglu S et al. Cochlear pathology in human temporal bones with otitis media. Acta Otolaryngol 2010; 130: 472-476.
20. Worsøe L, Brandt CT, Lund SP, Østergaard C, Thomsen J, Cayé-Thomasen P. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis. Laryngoscope 2010; 120: 1872-1879.
21. van de Beek D, Farrar JJ, de Gans J et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010; 9: 254-263.
22. Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010; 9: CD004405.
23. Klein M, Koedel U, Pfister HW, Kastenbauer S. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol 2003; 54: 451-458.
24. Demel C, Hoegen T, Giese A et al. Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis. J Neuroinflammation 2011; 8: 7.
25. Weinberger DM, Harboe ZB, Sanders EA et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51: 692-699.
26. Nabili V, Brodie HA, Neverov NI, Tinling SP. Chronology of labyrinthitis ossificans induced by Streptococcus pneumoniae meningitis. Laryngoscope 1999; 109: 931-935.
27. Waltzman SB, Fisher SG, Niparko JK, Cohen NL. Predictors of postoperative performance with cochlear implants. Ann Otol Rhinol Laryngol Suppl 1995; 165: 15-18.
28. Cohen NL, Hirsch BE. Current status of bacterial meningitis after cochlear implantation. Otol Neurotol 2010; 31: 1325-1328.
29. Merkus P, Free RH, Mylanus EA et al. 4th Consensus in Auditory Implants Meeting. Dutch Cochlear Implant Group (CI-ON) consensus protocol on postmeningitis hearing evaluation and treatment. Otol Neurotol 2010; 31: 1281-1286.